Sponsored by:

Nuclear Medicine: Page 178

SPECT V/Q detects early lung problems
By AuntMinnie.com staff writers
In vivo ventilation/perfusion (V/Q) SPECT imaging can detect early changes to lungs caused by cigarette smoke exposure and provides a noninvasive method for studying lung dysfunction in preclinical models, concluded a study published in the April issue of the Journal of Nuclear Medicine.
March 31, 2013
Report predicts $5.5B radiopharma market by 2017
By AuntMinnie.com staff writers
A new report by business research firm MarketsandMarkets predicts that the global radiopharmaceutical market will reach $5.5 billion by 2017, at a compound annual growth rate of 7.8%.
March 31, 2013
AMIC and GSG form strategic alliance
By AuntMinnie.com staff writers
Medical isotope producer Advanced Medical Isotope (AMIC) is collaborating with Swiss radionuclide manufacturer GSG International to jointly develop medical isotope production technologies and to market and distribute related isotopes, equipment, and services.
March 26, 2013
FDA clears new use for GE's AdreView SPECT tracer
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration has approved a new cardiac indication for the AdreView (iobenguane I-123 injection) SPECT radiopharmaceutical from GE Healthcare.
March 21, 2013
Lantheus moves to reduce expenses
By AuntMinnie.com staff writers
Diagnostic agent developer Lantheus Medical Imaging said on March 21 that it is taking steps to cut expenses, such as reducing internal R&D resources and seeking a partner to assist in the final development of one of its most promising PET radiopharmaceuticals.
March 21, 2013
GE promotes DaTscan study results at AAN meeting
By AuntMinnie.com staff writers
GE Healthcare is touting the results of a randomized study of DaTscan SPECT in adult patients with a diagnosis of possible dementia with Lewy bodies.
March 20, 2013
Piramal's florbetaben PET agent to be reviewed
By AuntMinnie.com staff writers
Piramal Imaging said that the U.S. Food and Drug Administration and the European Medicines Agency have accepted the company's applications for review of its florbetaben investigational PET amyloid imaging agent.
March 20, 2013
Lantheus lands Mo-99 supply deal
By AuntMinnie.com staff writers
Diagnostic agent developer Lantheus Medical Imaging has inked a five-year molybdenum-99 (Mo-99) supply contract with the Institute for Radioelements.
March 19, 2013
Bankruptcy judge finalizes sale of Gamma Medica business units
By Wayne Forrest
Gamma Medica has completed its Chapter 11 bankruptcy process with the separate sales of its molecular breast imaging and preclinical imaging business segments to two buyers.
March 18, 2013
2012 10 10 08 53 35 288 Luma Gem Thumb
IBA results improve in fiscal 2012
By AuntMinnie.com staff writers
Radiopharmaceutical provider Ion Beam Applications (IBA) benefited from increasing market adoption and expanded use of proton therapy treatment, increasing revenues for sales and services by 8.8% during its 2012 fiscal year compared with 2011.
March 18, 2013
SNMMI offers online dose information
By AuntMinnie.com staff writers
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has launched a new online resource for imaging professionals, referring physicians, and the public on dose optimization for nuclear medicine and molecular imaging procedures.
March 18, 2013
NuView touts breast cancer imaging agent study
By AuntMinnie.com staff writers
Radiopharmaceutical developer NuView Life Sciences is touting a phase I feasibility study of its NLS-VPAC1 breast cancer imaging agent.
March 17, 2013
Previous Page
Page 178 of 440
Next Page